Related Experiment Video
Updated: Dec 21, 2025

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
The emerging roles of WBP2 oncogene in human cancers
Hossein Tabatabaeian1,2, Angad Rao2, Alisha Ramos2
1Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.
Abstract:
WW domain-binding protein 2 (WBP2) is an emerging oncoprotein. Over the past decade, WBP2 surfaced as a key node connecting key signaling pathways associated with ER/PR, EGFR, PI3K, Hippo, and Wnt in cancer. In addition to the oncogenic functions of WBP2, this review discusses the latest research regarding the multilevel regulation and modes of action of WBP2 and how they can be exploited for molecular medicine. In translational research, evidence supports the role of WBP2 as a biomarker for early detection, prognosis, and companion diagnostics in breast cancer. Finally, we envision new trends in WBP2 research in the space of molecular etiology of cancer, targeted therapeutics, and precision medicine.
Insights
WW domain-binding protein 2 (WBP2) is an oncoprotein linking key cancer pathways. Research explores WBP2
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- WW domain-binding protein 2 (WBP2) is increasingly recognized as a significant oncoprotein.
- WBP2 acts as a central regulator, connecting critical signaling pathways such as ER/PR, EGFR, PI3K, Hippo, and Wnt in various cancers.
Purpose of the Study:
- To review the latest research on the multilevel regulation and mechanisms of action of WBP2.
- To explore the potential of WBP2 in molecular medicine and targeted cancer therapies.
- To highlight WBP2's role as a biomarker in breast cancer for early detection, prognosis, and companion diagnostics.
Main Methods:
- Literature review of recent studies on WBP2.
- Analysis of WBP2's role in cancer signaling pathways.
- Evaluation of translational research data regarding WBP2 as a biomarker.
Main Results:
- WBP2 integrates multiple oncogenic signaling pathways crucial for cancer development.
- Evidence supports WBP2's utility as a biomarker for breast cancer diagnosis and prognosis.
- WBP2's functions can be targeted for novel therapeutic strategies.
Conclusions:
- WBP2 is a key player in cancer etiology and progression.
- Targeting WBP2 offers potential for developing new cancer therapeutics and precision medicine approaches.
- Further research into WBP2's molecular mechanisms and clinical applications is warranted.
Related Concept Videos
Canonical Wnt Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway

